Our Pricing

Get Wegovy Online UK: Fast Prescription Assessment

Looking to get Wegovy online UK prescription without lengthy GP appointments? At Cured Pharmacy, our UK-registered clinical team provides a streamlined 3-minute assessment, transparent pricing from £79.00 and discreet home delivery of genuine UK-licensed Wegovy pens.

How to Get Wegovy Online UK: The Complete Process

Accessing Wegovy through our online pharmacy is straightforward and clinically safe. You'll complete a brief medical questionnaire reviewed by a UK-registered prescriber, typically within hours. This assessment evaluates your BMI, medical history, current medications, and suitability for semaglutide treatment.

Once approved, your prescription is sent electronically to our GPhC-registered pharmacy (9012511), where superintendent pharmacist Tarun Kumar (GPhC 2233073) and his team dispense your medication. Wegovy pens are shipped in discreet, temperature-controlled packaging to maintain the cold-chain integrity required for injectable semaglutide [1].

The entire process—from assessment to delivery—typically completes within 48 hours for most UK patients. All consultations are free, with pricing displayed upfront before you begin, ensuring complete transparency.

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone your gut releases after eating. This medication works through three distinct mechanisms: it slows gastric emptying so you feel fuller longer, reduces appetite signals in the brain, and improves insulin sensitivity [1].

In the landmark STEP 1 trial, participants using Wegovy alongside lifestyle modifications achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [2]. These results led to MHRA licensing and NICE guidance recommending semaglutide for weight management in eligible patients.

Wegovy is administered as a once-weekly subcutaneous injection, starting at 0.25mg and gradually increasing to a maintenance dose of 2.4mg over 16-20 weeks. This dose escalation minimises gastrointestinal side effects whilst allowing your body to adapt to the medication [1][2].

Who Can Use Wegovy?

Wegovy is licensed in the UK for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3]. Your prescriber will assess whether you meet these clinical criteria during your online consultation.

Wegovy vs Other Weight Loss Treatments

Several prescription weight loss medications are available through UK pharmacies, each with distinct mechanisms and clinical profiles. Semaglutide-based Wegovy differs from older options like orlistat, which blocks fat absorption, or combination treatments that work through appetite suppression alone.

Newer dual-action medications have shown higher average weight reductions in head-to-head trials, but Wegovy remains the most extensively studied GLP-1 treatment for weight management, with over 4,500 participants across the STEP trial programme [2][4]. Your prescriber will recommend the most appropriate option based on your medical history, treatment goals, and any contraindications.

All prescription weight loss medications work best alongside dietary changes and increased physical activity. NICE guidance emphasises that pharmacotherapy should complement, not replace, behavioural interventions for sustainable weight management [3].

Switching Between Treatments

Some patients begin with one medication and later switch based on tolerability or efficacy. If you're currently using another weight loss treatment, your UK prescriber will advise on appropriate washout periods and dose adjustments when transitioning to Wegovy.

Wegovy Dosing Schedule and Administration

Wegovy follows a structured dose escalation protocol designed to optimise tolerability. You'll begin with 0.25mg weekly for four weeks, then increase to 0.5mg, 1mg, 1.7mg, and finally 2.4mg maintenance dose. Each pen is pre-filled and single-use, with a hidden needle that automatically retracts after injection [1].

Injections are administered subcutaneously into the abdomen, thigh, or upper arm. Rotating injection sites reduces the risk of lipodystrophy. The medication should be stored in a refrigerator between 2-8°C until first use, after which it remains stable at room temperature for up to 28 days.

If you miss a dose and it's been less than five days, administer it as soon as you remember. If more than five days have passed, skip that dose and resume your regular schedule. Never double-dose to compensate for a missed injection [1].

Common Side Effects and Management Strategies

The most frequently reported side effects with Wegovy are gastrointestinal: nausea (44% of participants in STEP trials), diarrhoea (30%), vomiting (24%), and constipation (24%) [2]. These effects typically peak during dose escalation phases and diminish as your body adapts to semaglutide.

Practical management strategies include eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking the injection on the same day each week. If nausea persists, your prescriber may recommend temporarily maintaining your current dose before escalating further.

Rare but serious side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). Wegovy carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal link has been established in humans [1][3]. Your prescriber will review your personal and family medical history to identify any contraindications.

When to Contact Your Prescriber

Seek immediate medical advice if you experience severe abdominal pain, persistent vomiting, signs of pancreatitis, or symptoms of an allergic reaction such as rash, difficulty breathing, or facial swelling. Your prescriber can adjust your treatment plan or recommend alternative options if side effects become unmanageable.

Why Choose Cured Pharmacy for Your Wegovy Prescription

Our UK-registered pharmacy combines clinical expertise with genuine price transparency. Unlike services that reveal costs only after consultation, we display all pricing upfront, allowing you to make informed decisions before beginning your assessment. Our clinical team includes experienced prescribers who specialise in weight management and metabolic health.

Every Wegovy pen dispensed through Cured Pharmacy is sourced directly from UK-licensed wholesalers, ensuring full traceability and compliance with MHRA standards. We never supply grey-market or imported medications. Your prescription is reviewed by superintendent pharmacist Tarun Kumar (GPhC 2233073), who personally oversees our dispensing protocols.

Patients choose Cured Pharmacy for our combination of competitive pricing, rapid consultation turnaround, and discreet packaging. Our customer service team is available on (+44) 116 4646009 for any questions about your treatment, delivery, or ongoing care. We're committed to supporting your weight loss journey with evidence-based clinical guidance and reliable medication access.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 7 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 7 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 7 August 2026]
4. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 7 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 7 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 7 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 7 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.